Increased sensitivity to bradykinin among African Americans
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Background Angioedema is a potentially life-threatening side effect of angiotensin-converting enzyme (ACE) inhibitors. Although the mechanism of angioedema is not certain, bradykinin has been implicated in its pathogenesis. Compared with Caucasians, African Americans are at an increased risk of ACE inhibitor-associated angioedema, independent of ACE inhibitor dose or concurrent medications. Because urinary kallikrein levels are decreased in African Americans with hypertension, we hypothesized that endogenous bradykinin levels may be decreased in African Americans and that they therefore may be more sensitive to ACE inhibitor-induced increases in bradykinin or to exogenous bradykinin.Objective To test this hypothesis, we measured the wheal response to intradermal injection of bradykinin in salt-replete hypertensive and normotensive African Americans and Caucasians.Methods Two doses of bradykinin, 1 microgram and 10 micrograms, were administered on separate days in a randomized, double-blind fashion.Results Higher bradykinin dose (analysis of variance: F = 38.33, p < 0.001), African American race (analysis of variance: F = 17.90, p < 0.001), and hypertension (analysis of variance: F = 4.37, p = 0.05) were all associated with an increased wheal response to bradykinin.Conclusion These data provide additional support for racial differences in the kallikrein-kinin system and also implicate abnormalities of the tissue kallikrein-kinin system in essential hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prior studies suggest that black Americans exhibit increased sensitivity to the effects of bradykinin-induced vascular permeability compared to white Americans.[22]”
From Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema (2010) · cites this paper as [22]
Citations
Cites
Bradykinin receptors: Pharmacological properties and biological roles
Hall, J. M. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90016-s · Cited by 451
Brown, N. J., Ray, W. A., Snowden, M., & Griffin, M. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90161-7 · Cited by 313
Self-citationLevy, S. B., Lilley, J. J., Frigon, R. P., & Stone, R. A. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108749 · Cited by 221
Fields, T., Ghebrehiwet, B., & Kaplan, A. P. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90052-0 · Cited by 205
Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary Angioedema
Schapira, M., Silver, L. D., Scott, C. F., Schmaier, A. H., Prograis, L. J., Curd, J. G., & Colman, R. W. (1983) · New England Journal of Medicine · doi:10.1056/nejm198305053081802 · Cited by 199
Elliot, A. H., & Nuzum, F. R. (1934) · Endocrinology · doi:10.1210/endo-18-4-462 · Cited by 140
Pain and hyperalgesia after intradermal injection of bradykinin in humans
Manning, D. C., Raja, S. N., Meyer, R. A., & Campbell, J. N. (1991) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1991.212 · Cited by 136
Weir, M. R., Gray, J. M., Paster, R., & Saunders, E. (1995) · Hypertension · doi:10.1161/01.hyp.26.1.124 · Cited by 136
Angioedema: 5 Years' experience, with a review of the disorder's presentation and treatment
Megerian, C. A., Arnold, J. E., & Berger, M. (1992) · The Laryngoscope · doi:10.1288/00005537-199203000-00005 · Cited by 96
Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.
Ferner, R. E., Simpson, J. M., & Rawlins, M. D. (1987) · BMJ · doi:10.1136/bmj.294.6580.1119 · Cited by 88
Research works printed but not linked: 2
- Brown N, Ray W, Snowden M, Griffin M. African Americans have an increased rate of ACEI-associated angioedema. Clin Pharmacol Ther (in press).
- Emond, 1991, B2-kinin-binding sites in two-kidney, one-clip hypertensive rats, Am J Physiol, 260, F626
Cited by
Agostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646
“241 In this randomized, double-blind study, increased bradykinin dose, hypertension, and African American race each correlated with an increased wheal response to bradykinin.”
Douglas, J. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.525 · Cited by 438
ACE Inhibitor???Induced Angioedema: Incidence, Prevention and Management
Vleeming, W., van Amsterdam, J. G. C., Stricker, B. H., & de Wildt, D. J. (1998) · Drug Safety · doi:10.2165/00002018-199818030-00003 · Cited by 243
“Because urinary kallikrein levels are decreased in African Americans with hypertension it was hypothesised that endogenous bradykinin levels may be decreased in this population and that they therefore may be more sensitive to ACE inhibitor–induced increases in bradykinin[96] and thus to the induction of angioedema.”
BackgroundBanerji, A., Clark, S., Blanda, M., LoVecchio, F., Snyder, B., & Camargo, C. A. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60594-7 · Cited by 236
Nonallergic angioedema: role of bradykinin
Bas, M., Adams, V., Suvorava, T., Niehues, T., Hoffmann, T. K., & Kojda, G. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01427.x · Cited by 232
“7% (1, 2, 5, 8, 9), while Black people show a much greater susceptibility (10).”
Background
Metadata
- Authors
- Gainer, J. V., Nadeau, J. H., Ryder, D., & Brown, N. J.
- Affiliations
- Vanderbilt University Medical Center (US)
- ORCID
- Brown, Nancy J.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 1996-08
- Volume
- 98
- Issue
- 2
- Pages
- 283-287
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2030391290
- Cited by
- 89
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 3 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 3
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (RR 00095)
- National Institute of General Medical Sciences (GM-0756919, T32GM007569)
- National Center for Research Resources (M01RR000095, M01-RR 00095-533)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- bradykinin, ACE inhibitor-induced angioedema, African Americans, racial differences, kallikrein-kinin system, essential hypertension, urinary kallikrein
- MeSH terms
- Adolescent, Adult, Aged, Angioedema, Black or African American, Bradykinin, Double-Blind Method, Drug Hypersensitivity, Female, Humans, Hypertension, Intradermal Tests, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased sensitivity to bradykinin among African Americans. https://app.cochat.ai/papers/10.1016/s0091-6749(96)70151-3
- The paper
- Gainer, J. V., Nadeau, J. H., Ryder, D., & Brown, N. J. (1996). Increased sensitivity to bradykinin among African Americans. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/s0091-6749(96)70151-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.